The effects of 16-weeks of prebiotic supplementation and aerobic exercise training on inflammatory markers, oxidative stress, uremic toxins, and the microbiota in pre-dialysis kidney patients: a randomized controlled trial-protocol paper

Samuel A Headley, Donna J Chapman, Michael J Germain, Elizabeth E Evans, Jasmin Hutchinson, Karen L Madsen, Talat Alp Ikizler, Emily M Miele, Kristyn Kirton, Elizabeth O'Neill, Allen Cornelius, Brian Martin, Bradley Nindl, Nosratola D Vaziri, Samuel A Headley, Donna J Chapman, Michael J Germain, Elizabeth E Evans, Jasmin Hutchinson, Karen L Madsen, Talat Alp Ikizler, Emily M Miele, Kristyn Kirton, Elizabeth O'Neill, Allen Cornelius, Brian Martin, Bradley Nindl, Nosratola D Vaziri

Abstract

Background: Chronic kidney disease (CKD) is characterized by dysbiosis, elevated levels of uremic toxins, systemic inflammation, and increased markers of oxidative stress. These factors lead to an increased risk of cardiovascular disease (CVD) which is common among CKD patients. Supplementation with high amylose maize resistant starch type 2 (RS-2) can change the composition of the gut microbiota, and reduce markers of inflammation and oxidative stress in patients with end-stage renal disease. However, the impact of RS-2 supplementation has not been extensively studied in CKD patients not on dialysis. Aerobic exercise training lowers certain markers of inflammation in CKD patients. Whether combining aerobic training along with RS-2 supplementation has an additive effect on the aforementioned biomarkers in predialysis CKD patients has not been previously investigated.

Methods: The study is being conducted as a 16-week, double-blind, placebo controlled, parallel arm, randomized controlled trial. Sixty stage 3-4 CKD patients (ages of 30-75 years) are being randomized to one of four groups: RS-2 & usual care, RS-2 & aerobic exercise, placebo (cornstarch) & usual care and placebo & exercise. Patients attend four testing sessions: Two baseline (BL) sessions with follow up visits 8 (wk8) and 16 weeks (wk16) later. Fasting blood samples, resting brachial and central blood pressures, and arterial stiffness are collected at BL, wk8 and wk16. A stool sample is collected for analysis of microbial composition and peak oxygen uptake is assessed at BL and wk16. Blood samples will be assayed for p-cresyl sulphate and indoxyl sulphate, c-reactive protein, tumor necrosis factor α, interleukin 6, interleukin 10, monocyte chemoattractant protein 1, malondialdehyde, 8-isoprostanes F2a, endothelin-1 and nitrate/nitrite. Following BL, subjects are randomized to their group. Individuals randomized to conditions involving exercise will attend three supervised moderate intensity (55-65% peak oxygen uptake) aerobic training sessions (treadmills, bikes or elliptical machine) per week for 16 weeks.

Discussion: This study has the potential to yield information about the effect of RS-2 supplementation on key biomarkers believed to impact upon the development of CVD in patients with CKD. We are examining whether there is an additive effect of exercise training and RS-2 supplementation on these key variables.

Trial registration: Clinicaltrials.gov Trial registration# NCT03689569 . 9/28/2018, retrospectively registered.

Keywords: Inflammatory markers; Oxidative stress; Resistant starch; Uremic toxins.

Conflict of interest statement

The supplements (RS-2 and AMIOCA corn starch) were donated by Ingredion.

Figures

Fig. 1
Fig. 1
The schedule of enrollment, interventions, and assessments.*

References

    1. Saran R, Robinson B, Abbott KC, Bragg-Gresham J, Chen X, Gipson D, et al. US renal data system 2019 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2020;75(1):A6–A7. doi: 10.1053/j.ajkd.2019.09.003.
    1. Vaziri ND. CKD impairs barrier function and alters microbial flora of the intestine: a major link to inflammation and uremic toxicity. Curr Opin Nephrol Hypertens. 2012;21:587–592. doi: 10.1097/MNH.0b013e328358c8d5.
    1. Viana JL, Kosmadakis GC, Watson EL, Bevington A, Feehally J, Bishop NC, et al. Evidence for anti-inflammatory effects of exercise in CKD. J Am Soc Nephrol [Internet] 2014;25(9):2121–2130. doi: 10.1681/ASN.2013070702.
    1. Esgalhado M, Kemp JA, Azevedo R, Paiva BR, Stockler-Pinto MB, Dolenga CJ, et al. Could resistant starch supplementation improve inflammatory and oxidative stress biomarkers and uremic toxins levels in hemodialysis patients? A pilot randomized controlled trial. Food Funct. 2018;9(12):6508–6516. doi: 10.1039/C8FO01876F.
    1. Vaziri ND, Zhao Y, Pahl MV. Full Review Altered intestinal microbial fl ora and impaired epithelial barrier structure and function in CKD: the nature, mechanisms, consequences and potential treatment. 2015. pp. 1–10.
    1. Vaziri ND, Wong J, Pahl M, Piceno YM, Yuan J, Desantis TZ, et al. Chronic kidney disease alters intestinal microbial flora. Kidney Int. 2013;83(2):308–315. doi: 10.1038/ki.2012.345.
    1. Chiavaroli L, Mirrahimi A, Sievenpiper JL, Jenkins DJA, Darling PB. Dietary fi ber effects in chronic kidney disease: a systematic review and meta-analysis of controlled feeding trials. Eur J Clin Nutr. 2015;69:761–768. doi: 10.1038/ejcn.2014.237.
    1. Moraes C, Borges NA, Mafra D. Resistant starch for modulation of gut microbiota: Promising adjuvant therapy for chronic kidney disease patients? 2016. pp. 1813–1821.
    1. Sirich TL, Plummer NS, Gardner CD, Hostetter TH, Meyer TW. Effect of Increasing Dietary Fiber on Plasma Levels of Colon-Derived Solutes in Hemodialysis Patients. Clin J Am Soc Nephrol. 2018;9(9):1603–1610. doi: 10.2215/CJN.00490114.
    1. Vaziri ND, Liu S, Lau WL, Khazaeli M. High amylose resistant starch diet ameliorates oxidative stress , Inflammation , and Progression of Chronic Kidney Disease. 2014. pp. 1–15.
    1. Laffin MR, Tayebi Khosroshahi H, Park H, Laffin LJ, Madsen K, Kafil HS, et al. Amylose resistant starch (HAM-RS2) supplementation increases the proportion of Faecalibacterium bacteria in end-stage renal disease patients: microbial analysis from a randomized placebo-controlled trial. Hemodial Int. 2019;23(3):343–347.
    1. Kieffer DA, Piccolo BD, Vaziri ND, Liu S, Lau WL, Khazaeli M, et al. Resistant starch alters gut microbiome and metabolomic profiles concurrent with amelioration of chronic kidney disease in rats. 2016. p. 2.
    1. Ramos C, RG A, MEF C, MA D, Dolenga CJR, Nakao LS, et al. Effect of prebiotic (fructooligosaccharide) on uremic toxins of chronic kidney disease patients: a randomized controlled trial. Nephrol Dial Transplant. 2019;34:1876–1884. doi: 10.1093/ndt/gfy171.
    1. Clarke SF, Murphy EF, O’Sullivan O, Lucey AJ, Humphreys M, Hogan A, et al. Exercise and associated dietary extremes impact on gut microbial diversity. Gut. 2014;63(12):1913–1920. doi: 10.1136/gutjnl-2013-306541.
    1. Beavers KM, Brinkley TE, Nicklas BJ. Effect of exercise training on chronic inflammation. Clin Chim Acta. 2010;411(11–12):785–793. doi: 10.1016/j.cca.2010.02.069.
    1. Gleeson M, Bishop NC, Stensel DJ, Lindley MR, Mastana SS, Nimmo MA. The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease. 2011.
    1. Petersen AMW, Pedersen BK. The anti-inflammatory effect of exercise. J Appl Physiol. 2005;98:1154–1162. doi: 10.1152/japplphysiol.00164.2004.
    1. Reibe D, Ehrman J, Liguori G, Magal M. In: ACSM’s guidelines for exercise testing and prescription. 10. Riebe D, Ehrman J, Gary Liguori MM, editors. Philadelphia: Wolters Kluwer; 2018.
    1. Baer DJ, Stote KS, Henderson T, Paul DR, Okuma K, Tagami H, et al. The Metabolizable Energy of Dietary Resistant Maltodextrin Is Variable and Alters Fecal Microbiota Composition in Adult Men 1–3. 2014. pp. 1023–1030.
    1. de Loor H, Meijers BK, Meyer TW, Bammens B, Verbeke KDehaen WEP. Sodium octanoate to reverse indoxyl sulfate and p-cresyl sulfate albumin binding in uremic and normal serum during sample preparation followed by fluorescence liquid chromatography. J Chromatogr. 2009;1216(22):4684–4688. doi: 10.1016/j.chroma.2009.04.015.
    1. Bolyen E, Rideout JR, Dillon MR, Bokulich NA, Abnet CC, Al-Ghalith GA, et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat Biotechnol. 2019;37(8):852–857. doi: 10.1038/s41587-019-0209-9.
    1. Metwally AA, Yang J, Ascoli C, Dai Y, Finn PW, Perkins DL. MetaLonDA: A flexible R package for identifying time intervals of differentially abundant features in metagenomic longitudinal studies. Microbiome. 2018;6(1):1–12. doi: 10.1186/s40168-018-0402-y.
    1. Wang M. Generalized estimating equations in longitudinal data analysis: A review and recent developments. Adv Stat. 2014;2014:1–11.
    1. Viana JL, Kosmadakis GC, Watson EL, Bevington A, Feehally J, Bishop NC, et al. Evidence for Anti-In fl ammatory Effects of Exercise in CKD. 2014. pp. 2121–2130.
    1. Howden EJ, Coombes JS, Strand H, Douglas B, Campbell KL, Isbel NM. Exercise training in CKD: efficacy, adherence, and safety. Am J Kidney Dis. 2015;65(4):583–591. doi: 10.1053/j.ajkd.2014.09.017.
    1. Allen JM, Mailing LJ, Niemiro GM, Moore R, Cook MD, White BA, et al. Exercise alters gut microbiota composition and function in lean and obese humans. Med Sci Sports Exerc. 2018;50(4):747–757. doi: 10.1249/MSS.0000000000001495.
    1. Mailing LJ, Allen JM, Buford TW, Fields CJ, Woods JA. Exercise and the gut microbiome: A review of the evidence, potential mechanisms, and implications for human health. Exerc Sport Sci Rev. 2019;47(2):75–85. doi: 10.1249/JES.0000000000000183.
    1. Andersen K, Kesper MS, Marschner JA, Konrad L, Ryu M, Demleitner J, et al. Intestinal Dysbiosis , Barrier Dysfunction , and Bacterial Translocation Account for CKD – Related Systemic Inflammation. 2016. pp. 1–8.
    1. Vaziri ND, Zhao Y, Pahl MV. Altered intestinal microbial flora and impaired epithelial barrier structure and function in CKD: the nature , mechanisms , consequences and potential treatment. 2017. pp. 737–746.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner